Detalhe da pesquisa
1.
Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis.
Thorax
; 79(2): 169-178, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135489
2.
Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
Clin Infect Dis
; 76(3): e1408-e1415, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607719
3.
Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020.
Emerg Infect Dis
; 29(7): 1415-1419, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37347810
4.
Impact of COVID-19 on Tuberculosis Prevention and Treatment in Canada: A Multicenter Analysis of 10 833 Patients.
J Infect Dis
; 225(8): 1317-1320, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919700
5.
Increasing and More Commonly Refractory Mycobacterium avium Pulmonary Disease, Toronto, Ontario, Canada.
Emerg Infect Dis
; 28(8): 1589-1596, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876492
6.
Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.
Emerg Infect Dis
; 28(9): 1814-1823, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997366
7.
Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB).
BMC Infect Dis
; 21(1): 254, 2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691624
8.
Treatment outcomes of nontuberculous mycobacterial pulmonary disease in lung transplant recipients.
Transpl Infect Dis
; 23(4): e13679, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34184393
9.
Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001-2012.
Emerg Infect Dis
; 26(9): 2097-2107, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818392
10.
Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis.
Eur Respir J
; 55(3)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31862767
11.
Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001-2013.
Emerg Infect Dis
; 25(7)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31215507
12.
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Lancet
; 392(10150): 821-834, 2018 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30215381
13.
Radiologic types of Mycobacterium xenopi pulmonary disease: different patients with similar short-term outcomes.
Eur J Clin Microbiol Infect Dis
; 38(2): 373-381, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552538
14.
Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection.
CMAJ
; 195(18): E650-E651, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156559
15.
Tests cutanés à la tuberculine et tests de libération de l'interféron γ pour le diagnostic de l'infection tuberculeuse.
CMAJ
; 195(35): E1196-E1197, 2023 09 11.
Artigo
em Francês
| MEDLINE | ID: mdl-37696555
16.
Mycobacterium xenopi Genotype Associated with Clinical Phenotype in Lung Disease.
Lung
; 196(2): 213-217, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29349535
17.
Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada.
Emerg Infect Dis
; 23(11): 1898-1901, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29048292
18.
Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013.
Emerg Infect Dis
; 23(3): 468-476, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28221106
19.
The risk of mycobacterial infections associated with inhaled corticosteroid use.
Eur Respir J
; 50(3)2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28931659
20.
Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review.
Respirology
; 21(6): 1015-25, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27009804